Womens Mitchum Clinical Antiperspirant Deodorant
FDA Label NDC 10967-595

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Revlon Consumer Products Corp for the product Womens Mitchum Clinical Antiperspirant Deodorant (NDC 10967-595). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug factsactive ingredient, purpose, use, warnings:, keep out of reach of children., directions, inactive ingredients, questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Drug Factsactive Ingredient

Aluminum zirconium tetrachlorohydrex gly 20%

Purpose

Antiperspirant

Use

  • Reduces underarm wetness

Warnings:

For external use only.

Do not use on broken skin

Ask a doctor before use if you have kidney disease

Stop use if rash or irriation occurs

Keep Out Of Reach Of Children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Apply to underarms only.

Inactive Ingredients

cyclopentasiloxane, tribehenin, dimethicone, parfum (fragrance), petrolatum, trisiloxane, c18-36 acid triglyceride, hydrogen peroxide, tocopheryl acetate, aloe barbadensis leaf extract, sodium starch octenylsuccinate, aqua((water) eau), silica dimethicone silylate, silica, benzyl salicylate, linalool, limonene, hexyl cinnamal, coumarin, citronellol, geraniol, cinnamyl alcohol, citral 

Questions

1-888-8-MITCHUM

* Please review the disclaimer below.